Brief: MedCap Q4 EBITDA Rises To SEK 37.5 Mln

MedCap AB (publ)

17/02/2020 06:54

Feb 17 (Reuters) - MedCap AB  MEDCAP.ST :
    * Q4 NET SALES SEK 211.1 MLN VS SEK 187.7 MLN YR AGO
    * Q4 EBITDA SEK 37.5 MLN VS SEK 17.0 MLN YR AGO
    * POSITIVE DEVELOPMENT IS PRIMARILY DRIVEN BY PROFIT GROWTH
IN
MEDICAL TECHNOLOGY, WHERE THE BUSINESS CONTINUES TO DEVELOP WELL
WITH ORGANIC SALES GROWTH AND EXPANDING MARGINS

    
 Source text for Eikon:  urn:newsml:reuters.com:*:nWkr67lZQd
    
 Further company coverage:  MEDCAP.ST  
   
   


 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10))